Position in MGNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$313,790
+$203,027 QoQ
Shares Held
67,920
-22.1% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 122 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. MGNX ranks #219 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in MGNX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $313,790 | 67,920 | Shares | Sole | 2026-08-12 | |
| 2025-03-31 | $110,763 | 87,215 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $276,955 | 85,217 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $271,974 | 82,667 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $375,249 | 88,294 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,370,417 | 93,099 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $870,119 | 90,449 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $422,540 | 90,674 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $483,201 | 90,318 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $684,132 | 95,416 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $628,290 | 93,635 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $321,233 | 92,842 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $258,971 | 87,787 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $560,183 | 63,585 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,029,735 | 64,158 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,352,849 | 64,606 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,662,311 | 61,888 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,509,525 | 78,792 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,929,932 | 84,424 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,856,326 | 73,693 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,305,382 | 82,571 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $424,603 | 72,956 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||